333 related articles for article (PubMed ID: 7964945)
1. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
3. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy.
Scambia G; Panici PB; Baiocchi G; Amoroso M; Foti E; Greggi S; Mancuso S
Am J Obstet Gynecol; 1991 Feb; 164(2):631-6. PubMed ID: 1992715
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Ferrandina G; Macchia G; Legge F; Deodato F; Forni F; Digesù C; Carone V; Morganti AG; Scambia G
Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
8. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
11. Multiple tumour marker assays in advanced cervical cancer: relationship to chemotherapy response and clinical outcome.
Scambia G; Benedetti Panici ; Foti E; Ferrandina G; Leone FP; Marciano M; Mancuso S
Eur J Cancer; 1996 Feb; 32A(2):259-63. PubMed ID: 8664038
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
13. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
Chen P; Jiao L; Ren F; Wang DB
BMC Cancer; 2020 May; 20(1):423. PubMed ID: 32410650
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
Guo Q; Zhu J; Wu Y; Wen H; Xia L; Wu X; Ju X
Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
18. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
[TBL] [Abstract][Full Text] [Related]
20. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]